2024/2606(DEA)
Inclusion of the drug precursor Isopropylidene (2-(3,4-methylenedioxyphenyl)acetyl)malonate (IMDPAM) and other substances in the list of scheduled substances
Basic information
2024/2606(DEA)
DEA - Delegated acts procedure
Subject
7.30.30.04 Action to combat drugs and drug-trafficking
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed LÓPEZ AGUILAR Juan Fernando (S&D)
04/04/2024
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 28/02/2024 | Non-legislative basic document published | C(2024)01219 | |
| 28/02/2024 | Initial period for examining delegated act 2.0 month(s) | ||
| 13/03/2024 | Committee referral announced in Parliament | ||
| 12/04/2024 | Delegated act not objected by Council | ||
| 23/04/2024 | Decision by Parliament | T9-0314/2024 |
Technical information
| Procedure | Information |
|---|---|
| Procedure reference | 2024/2606(DEA) |
| Procedure type | DEA - Delegated acts procedure |
| Nature of procedure | Examination of delegated act |
| Legal basis | Rules of Procedure EP 0114-p6 |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
LIBE/9/14299
|
Documentation gateway
-
Document type Committee Reference Date Summary Recommendation for early non-objection of delegated act B9-0213/2024 10/04/2024 Text adopted by Parliament, single reading T9-0314/2024 23/04/2024 -
Document type Reference Date Summary Non-legislative basic document C(2024)01219 28/02/2024